Retatrutide 30mg

Retatrutide 30mg

Retatrutide (Triple Agonist) Retatrutide is one of the most advanced next-generation peptides available for scientific research today. It is a precision-engineered "triple agonist" molecule targeting GLP-1, GIP, and Glucagon receptors. Current studies focus on its potential influence on energy expenditure, lipid metabolism, and comprehensive weight regulation models.

Why Researchers Choose Perth Peptides Every batch of Retatrutide is produced to pharmaceutical-grade standards. Our rigorous quality control ensures ≥99% purity, validated by independent analysis. Researchers rely on our formulation for its consistency, solubility, and reproducible performance in complex receptor studies.

Product Highlights

Purity: ≥99% (independently verified)

Solubility: Excellent solubility in aqueous buffers

Manufacturing: GMP compliant

Use: Advanced metabolic, lipid, and triple-receptor research

Form: Stable lyophilised powder

Storage Keep sealed and stored dry at 2–8 °C. Once reconstituted, refrigerate and use within 6 weeks.

Disclaimer: For research and laboratory use only. Not for human consumption.